Price movement over the last 24 hours
Align Technology, Inc. vs Vanguard High Dividend Yield ETF — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Vanguard High Dividend Yield ETF trades at $161.69. The key difference: Vanguard High Dividend Yield ETF is trading nearer its 52-week high, Align Technology, Inc. nearer its low. Which is the better fit depends on your goals.
| ALGN | VYM | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | — |
52-Week High | $207.19 | $161.17 |
52-Week Low | $124.88 | $132.90 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
VYM trades at $161.06, up 0.32% with a bullish technical outlook supported by moving averages. The ETF focuses on high dividend yield stocks, offering income generation through quarterly distributions. Recent news highlights strong investor interest in dividend ETFs for retirement income, with VYM frequently compared to peers like VIG and SCHD for its diversified portfolio and low expense ratio.
The outlook remains positive for income-focused investors, with VYM providing stable dividend payments amid market volatility. Key risks include interest rate sensitivity and economic downturns affecting dividend sustainability. Analyst sentiment is generally favorable, emphasizing its role in balanced portfolios for long-term income generation.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →